Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer

A promising molecular target for aggressive cancers is the urokinase receptor (uPAR). A fully human, recombinant antibody that binds uPAR to form a stable complex that blocks uPA-uPAR interactions (2G10) and is internalized primarily through endocytosis showed efficacy in a mouse xenograft model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Harel, Efrat T., Drake, Penelope M., Barfield, Robyn M., Lui, Irene, Farr-Jones, Shauna, Van’t Veer, Laura, Gartner, Zev J., Green, Evan M., Lourenço, André Luiz, Cheng, Yifan, Hann, Byron C., Rabuka, David, Craik, Charles S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963874/
https://www.ncbi.nlm.nih.gov/pubmed/31694242
http://dx.doi.org/10.3390/antib8040054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963874/
https://www.ncbi.nlm.nih.gov/pubmed/31694242
http://dx.doi.org/10.3390/antib8040054

Ejemplares similares